Levonadifloxacin, a Novel Broad-Spectrum Anti-MRSA Benzoquinolizine Quinolone Agent: Review of Current Evidence.

导出 LinkOut

翻译打印收藏纠错

作者： Sachin S,Bhagwat ^[1] ; Manohar,Nandanwar ^[2] ; Atul,Kansagara ^[2] ; Anusuya,Patel ^[3] ; Swapna,Takalkar ^[1] ; Rajesh,Chavan ^[4] ; Hariharan,Periasamy ^[1] ; Ravindra,Yeole ^[5] ; Prasad K,Deshpande ^[6] ; Satish,Bhavsar ^[6] ; Ashima,Bhatia ^[7] ; Jaishid,Ahdal ^[8] ; Rishi,Jain ^[8] ; Mahesh,Patel ^[9]

作者单位： Department of Microbiology, Wockhardt Research Centre, Aurangabad, India. ^[1] Department of Toxicology, Wockhardt Research Centre, Aurangabad, India. ^[2] Department of Safety Pharmacology, Wockhardt Research Centre, Aurangabad, India. ^[3] Department of Drug Metabolism and Pharmacokinetics, Wockhardt Research Centre, Aurangabad, India. ^[4] Department of Analytical Chemistry, Wockhardt Research Centre, Aurangabad, India. ^[5] Department of Medicinal Chemistry, Wockhardt Research Centre, Aurangabad, India. ^[6] Global Clinical Operations, Wockhardt Ltd, Mumbai, India. ^[7] Department of Medical Affairs, Wockhardt Ltd, Mumbai, India. ^[8] Drug Discovery Research, Wockhardt Research Centre, Aurangabad, India. ^[9]

关键词 MRSA WCK 2349 WCK 771 alalevonadifloxacin broad?-spectrum antibiotic levonadifloxacin